Cello has confirmed that it has achieved results in line with market expectations for 2015. Full year LFL growth is expected to be c4%, with both units at a similar level. The Health business Is making good progress with its North American expansion. The majority of the Health business is growing well (c80%) with only the small Consumer business down on project deferrals. The balance of services in health makes the business robust. Signal business now operates under one incentive structure and is being marketed under the Cello Signal brand. Won RBS advertising creative off M&C Saatchi and there is scope to expand the relationship. This marks a radical improvement in Signals business position and highlights the improved state of the offering. The VAT situation is unchanged and there is no change to liability estimate. On outlook the Company indicates a good start to 2016 and we understand visibility is good in both businesses. Due to equity market weakness the shares have drifted into value territory and we will review our numbers and view in more detail.